Annotation Detail for SCARF2
Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of SCARF2 mRNA | decreases expression | 20458559
|
| C034028 |
vanadyl sulfate |
vanadyl sulfate results in decreased expression of SCARF2 mRNA | decreases expression | 16330358
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
2.37 | 11798837 19825857 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
4.22 | 16206674 |
| MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.94 | 11589617 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
1.99 | 11135700 14691202 15073043 16217749 15553829 |
| MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.94 | 19014326 |
| MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.63 | 12490120 |
| MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.87 | 20501625 |
| MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.86 | 12609071 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
1.90 | 10525206 |
| MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.70 | 15213294 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
vanadyl sulfate |
4.81 | 16684804 |
| MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.40 | 12903497 |
| MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
3.84 | 15073043 |
| MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.94 | 16904648 |
| MESH:D007938 |
Leukemia |
|
arsenic trioxide |
3.03 | 15070760 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
4.35 | 17077332 12560223 |
| MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
5.19 | 16972261 |
| MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.79 | 14633726 |
| MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
4.31 | 19077051 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.19 | 19850784 17050201 16467208 20471514 16968895 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.51 | 17107899 12679006 11468182 19075265 12018890 11161223 9834237 15336539 15748426 16891316 16112521 15622746 16331271 17649720 12712474 17869043 17217047 19225113 19642359 16966277 19035177 15213294 16823087 16330433 17712046 |
| MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
5.03 | 16882451 |
| MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
2.48 | 14682389 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
3.01 | 20377131 |
| MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.73 | 15213294 |
| MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
1.87 | 11798837 19825857 |
| MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.44 | 11468182 19549372 15949261 19417148 14977855 |
| MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
5.74 | 18349030 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.38 | 16882451 16105982 |
| MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.63 | 16624393 |
| MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.41 | 10525206 |
| MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.52 | 16624393 12452020 19769630 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.66 | 15580305 |
| MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.77 | 19927285 |
| MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.20 | 19131511 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.63 | 16646077 |
| MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
1.86 | 17007042 |
| MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.47 | 19014326 |
| MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.85 | 15213294 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
2.62 | 12973940 11780464 20435036 12845720 |
Related Pathway Information